Literature DB >> 12810639

Methoxyestrogens exert feedback inhibition on cytochrome P450 1A1 and 1B1.

Sheila Dawling1, Nady Roodi, Fritz F Parl.   

Abstract

Cytochrome P450 1A1 (CYP1A1) and 1B1 (CYP1B1) catalyze the oxidative metabolism of 17 beta-estradiol (E2) to catechol estrogens (2-OHE2 and 4-OHE2) and estrogen quinones, which may lead to DNA damage. Catechol-O-methyltransferase catalyzes the methylation of catechol estrogens to methoxyestrogens (2-MeOE2, 2-OH-3-MeOE2, and 4-MeOE2), which simultaneously lowers the potential for DNA damage and increases the concentration of 2-MeOE2, an antiproliferative metabolite. In this study, we showed that CYP1A1 and CYP1B1 recognized as substrates both the parent hormone E2 and the methoxyestrogens. Using purified recombinant enzymes, we demonstrated that CYP1A1 and CYP1B1 O-demethylated the methoxyestrogens to catechol estrogens according to Michaelis-Menten kinetics. Both CYP1A1 and CYP1B1 demethylated 2-MeOE2 and 2-OH-3-MeOE2 to 2-OHE2, whereas CYP1B1 additionally demethylated 4-MeOE2 to 4-OHE2. Because the P450-mediated oxidation of E2 and the O-demethylation of methoxyestrogens both yielded identical catechol estrogens as products, we used deuterated E2 (E2-d4), unlabeled methoxyestrogens, and gas chromatography/mass spectrometry to examine both reactions simultaneously. Kinetic analysis revealed that methoxyestrogens acted as noncompetitive inhibitors of E2 oxidation with K(i) ranging from 27 to 153 micro M. For both enzymes, the order of inhibition by methoxyestrogens was 2-OH-3-MeOE2 > or = 2-MeOE2 > 4-MeOE2. Thus, methoxyestrogens exert feedback inhibition on CYP1A1- and CYP1B1-mediated oxidative estrogen metabolism, thereby reducing the potential for estrogen-induced DNA damage.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12810639

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  19 in total

1.  Tetra-methoxystilbene modulates ductal growth of the developing murine mammary gland.

Authors:  Taehyun Kim; Hoyong Park; Wei Yue; Ji-Ping Wang; Kristen A Atkins; Zhenguo Zhang; Eleanor G Rogan; Ercole L Cavalieri; Khalid S Mohammad; Sanghee Kim; Richard J Santen; Sarah E Aiyar
Journal:  Breast Cancer Res Treat       Date:  2010-12-18       Impact factor: 4.872

Review 2.  Depurinating estrogen-DNA adducts in the etiology and prevention of breast and other human cancers.

Authors:  Ercole L Cavalieri; Eleanor G Rogan
Journal:  Future Oncol       Date:  2010-01       Impact factor: 3.404

3.  2-Methoxyestradiol Attenuates Angiotensin II-Induced Hypertension, Cardiovascular Remodeling, and Renal Injury.

Authors:  Eman Salah; Sheldon I Bastacky; Edwin K Jackson; Stevan P Tofovic
Journal:  J Cardiovasc Pharmacol       Date:  2019-03       Impact factor: 3.105

Review 4.  Estrogen metabolism and breast cancer.

Authors:  Hamed Samavat; Mindy S Kurzer
Journal:  Cancer Lett       Date:  2014-04-28       Impact factor: 8.679

Review 5.  Unbalanced metabolism of endogenous estrogens in the etiology and prevention of human cancer.

Authors:  Ercole L Cavalieri; Eleanor G Rogan
Journal:  J Steroid Biochem Mol Biol       Date:  2011-03-21       Impact factor: 4.292

6.  Associations differ by sex for catechol-O-methyltransferase genotypes and bladder cancer risk in South Egypt.

Authors:  Beverly J Wolpert; Sania Amr; Doa'a A Saleh; Sameera Ezzat; Iman Gouda; Iman Loay; Tamer Hifnawy; Mohamed Abdel-Hamid; Nabiel N Mikhail; Min Zhan; Yun-Ling Zheng; Katherine Squibb; Mohamed A Abdel-Aziz; Mohamed S Zaghloul; Hussein Khaled; Christopher A Loffredo
Journal:  Urol Oncol       Date:  2011-03-11       Impact factor: 3.498

7.  2-Methoxyestradiol, an endogenous 17β-estradiol metabolite, inhibits microglial proliferation and activation via an estrogen receptor-independent mechanism.

Authors:  Sara A Schaufelberger; Marinella Rosselli; Federica Barchiesi; Delbert G Gillespie; Edwin K Jackson; Raghvendra K Dubey
Journal:  Am J Physiol Endocrinol Metab       Date:  2016-01-05       Impact factor: 4.310

8.  Structure-Based Design and Synthesis of New Estrane-Pyridine Derivatives as Cytochrome P450 (CYP) 1B1 Inhibitors.

Authors:  Raphaël Dutour; Francisco Cortés-Benítez; Jenny Roy; Donald Poirier
Journal:  ACS Med Chem Lett       Date:  2017-10-11       Impact factor: 4.345

9.  The etiology and prevention of breast cancer.

Authors:  Ercole L Cavalieri; Eleanor G Rogan
Journal:  Drug Discov Today Dis Mech       Date:  2012

10.  Estrogen exposure, metabolism, and enzyme variants in a model for breast cancer risk prediction.

Authors:  Fritz F Parl; Kathleen M Egan; Chun Li; Philip S Crooke
Journal:  Cancer Inform       Date:  2009-05-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.